Frank Verholen

Vice President and Head of GU Franchise, Bayer

As an experienced physician, Dr. Frank Verholen also knows the daily routine in the clinic and can combine the great wealth of knowledge of medical practice with the pharmacological innovations, e.g. from Bayer.  Frank Verholen studied medicine at the Ruhr University in Bochum and completed his doctorate there. He then worked for more than 10 years at the University Hospitals of Geneva, where he acquired his knowledge for training as a specialist in internal medicine as well as a specialist in hematology. Dr. Verholen initially worked in various positions in the pharmaceutical industry in Switzerland and Germany, as well on a European level, before he took on the global medical responsibility at Bayer for radium-223 in 2016. For several years, he has headed the medical department for the urogenital division, including prostate cancer, in the Bayer Oncology Business Unit.

Updated: November 2021